Science Explorer Back to mapMap
Discussion
Company · Mississauga · Canada

Nuvo Pharmaceuticals (Canada)

Research works
15
▲ 294% vs 2018-21
Citations
466
31.0 per fractional work
Top-10% rate
9.1%
all institutions 10.0%
Open access
36%
world 40%
International
46%
world 18%

Not ranked overall: Nuvo Pharmaceuticals (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Nuvo Pharmaceuticals (Canada) work in?

In all years, 50% of research at Nuvo Pharmaceuticals (Canada) is in Health Sciences, 23% in Life Sciences. Its largest fields are Medicine (50%), Computer Science (13%), Neuroscience (10%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 8 fractional works · 50.0% of its workMedicine: 8 fractional works · 50.0% of its workPharmacology: 1 fractional works · 8.7% of its workDermatology: 1 fractional works · 7.4% of its workPsychiatry and Mental health: 1 fractional works · 6.6% of its workRheumatology: 1 fractional works · 6.0% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.3% of its workPhysiology: 0 fractional works · 2.7% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 2.2% of its workSurgery: 0 fractional works · 1.9% of its workEmergency Medicine: 0 fractional works · 1.5% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.4% of its workOncology: 0 fractional works · 1.3% of its workEpidemiology: 0 fractional works · 1.1% of its workImmunology and Allergy: 0 fractional works · 1.1% of its workOtorhinolaryngology: 0 fractional works · 1.1% of its workRehabilitation: 0 fractional works · 1.1% of its workInfectious Diseases: 0 fractional works · 0.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.7% of its workLife Sciences: 3 fractional works · 23.2% of its workNeuroscience: 1 fractional works · 9.8% of its workCellular and Molecular Neuroscience: 1 fractional works · 8.8% of its workCognitive Neuroscience: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 7.8% of its workMolecular Biology: 1 fractional works · 7.8% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 5.2% of its workPharmaceutical Science: 1 fractional works · 5.2% of its workImmunology and Microbiology: 0 fractional works · 0.5% of its workVirology: 0 fractional works · 0.5% of its workPhysical Sciences: 3 fractional works · 20.7% of its workComputer Science: 2 fractional works · 12.6% of its workInformation Systems: 1 fractional works · 5.0% of its workArtificial Intelligence: 1 fractional works · 4.5% of its workComputer Vision and Pattern Recognition: 0 fractional works · 3.3% of its workEnvironmental Science: 1 fractional works · 4.5% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 2.2% of its workEnvironmental Engineering: 0 fractional works · 1.5% of its workGlobal and Planetary Change: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 2.2% of its workOrganic Chemistry: 0 fractional works · 2.2% of its workEngineering: 0 fractional works · 1.5% of its workBuilding and Construction: 0 fractional works · 0.7% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.7% of its workSocial Sciences: 1 fractional works · 6.0% of its workDecision Sciences: 0 fractional works · 3.1% of its workInformation Systems and Management: 0 fractional works · 2.6% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.5% of its workSocial Sciences: 0 fractional works · 2.9% of its workPolitical Science and International Relations: 0 fractional works · 2.2% of its workTransportation: 0 fractional works · 0.7% of its workALL ITS WORKNuvoPharmaceuticals…15fractional works, all years
Life Sciences23%Physical Sciences21%Health Sciences50%Social Sciences6%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Medicine850.0%
    1. Neuroscience19.8%
    2. Biochemistry, Genetics and Molecular Biology17.8%
    3. Pharmacology, Toxicology and Pharmaceutics15.2%
    4. Immunology and Microbiology00.5%
    1. Computer Science212.6%
    2. Environmental Science14.5%
    3. Chemistry02.2%
    4. Engineering01.5%
    1. Decision Sciences03.1%
    2. Social Sciences02.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Nuvo Pharmaceuticals (Canada)?

The most cited paper from Nuvo Pharmaceuticals (Canada) is "Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis" (Lee S. Simon, Lisa M. Grierson, Zahid Naseer et al., 2009), with 197 citations. Next come "Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial" (190) and "Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]" (104).

Most cited papers
#PaperReleasedCitations
1 Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis Lee S. Simon, Lisa M. Grierson, Zahid Naseer et al. · Pain 20 Apr 2009 197
2 Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial ARTHUR A.M. BOOKMAN · Canadian Medical Association Journal Open access 16 Aug 2004 190
3 Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886] Philip A. Baer, Lisa M. Black Thomas, Zev Shainhouse · BMC Musculoskeletal Disorders Open access 8 Aug 2005 104
4 The Dimensions of Pain Quality: Factor Analysis of the Pain Quality Assessment Scale Timothy W. Victor, Mark P. Jensen, Arnold R. Gammaitoni et al. · Clinical Journal of Pain 16 Jun 2008 94
5 In Vivo Bioavailability and Metabolism of Topical Diclofenac Lotion in Human Volunteers Xiaoying Hui, Philip G. Hewitt, Nicholas Poblete et al. · Pharmaceutical Research Oct 1998 64
All 19 most cited papers, with filters and sorting

Which research topics does Nuvo Pharmaceuticals (Canada) publish most on?

By volume in 2022-now: Information Retrieval and Search Behavior, Data Visualization and Analytics, Scientific Computing and Data Management and Topic Modeling.

  1. 1 Information Retrieval and Search Behavior Information Systems 0 works
  2. 2 Data Visualization and Analytics Computer Vision and Pattern Recognition 0 works
  3. 3 Scientific Computing and Data Management Information Systems and Management 0 works
  4. 4 Topic Modeling Artificial Intelligence 0 works
  5. 5 Artificial Intelligence in Law Political Science and International Relations 0 works
  6. 6 Multi-Agent Systems and Negotiation Artificial Intelligence 0 works
  7. 7 Soil Moisture and Remote Sensing Environmental Engineering 0 works
  8. 8 Web Data Mining and Analysis Information Systems 0 works
  9. 9 Research Data Management Practices Information Systems 0 works
  10. 10 Plant Water Relations and Carbon Dynamics Global and Planetary Change 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.5%not open63.5%

World: 40% of research is openly available.

with international co-authors45.7%domestic only54.3%

World: 18% is written across borders.

How has Nuvo Pharmaceuticals (Canada)'s research output changed?

Output in 2022-2025 was 294% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Nuvo Pharmaceuticals (Canada) as a percentage of every work published that year, 0.0000025% in 2022.

still counting0.000050%0.00010%Nuvo Pharmaceuticals (Canada)0.000020% in 2025200020102020

Fractional works of Nuvo Pharmaceuticals (Canada) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Mississauga

All research institutions in Mississauga

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Nuvo Pharmaceuticals (Canada). Posts are plain text and can be reported.